vimarsana.com

Latest Breaking News On - Nasdaq cdmo - Page 5 : vimarsana.com

Scissortail Wealth Management LLC Makes New Investment in Avid Bioservices, Inc (NASDAQ:CDMO)

Scissortail Wealth Management LLC acquired a new position in Avid Bioservices, Inc. (NASDAQ:CDMO – Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,867 shares of the biopharmaceutical company’s stock, valued at approximately $304,617,000. Other large investors have […]

Avid Bioservices (NASDAQ:CDMO) Trading Down 5%

Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report) shares dropped 5% during trading on Monday . The company traded as low as $13.21 and last traded at $13.21. Approximately 163,575 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 573,647 shares. The stock had previously closed at $13.91. […]

KeyCorp Brokers Cut Earnings Estimates for Avid Bioservices, Inc (NASDAQ:CDMO)

Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) – Equities research analysts at KeyCorp lowered their FY2024 earnings per share estimates for shares of Avid Bioservices in a report released on Wednesday, June 21st. KeyCorp analyst P. Knight now forecasts that the biopharmaceutical company will earn ($0.07) per share for the year, down from their previous […]

Avid Bioservices (NASDAQ:CDMO) PT Lowered to $20 00 at Stephens

Avid Bioservices (NASDAQ:CDMO – Get Rating) had its price target lowered by Stephens from $24.00 to $20.00 in a report released on Thursday, The Fly reports. Separately, Royal Bank of Canada restated an outperform rating and set a $20.00 target price on shares of Avid Bioservices in a research report on Tuesday, March 14th. Avid […]

Royal Bank of Canada Trims Avid Bioservices (NASDAQ:CDMO) Target Price to $17 00

Avid Bioservices (NASDAQ:CDMO – Get Rating) had its target price reduced by Royal Bank of Canada from $20.00 to $17.00 in a research note issued to investors on Thursday morning, The Fly reports. Separately, Stephens reduced their price objective on shares of Avid Bioservices from $24.00 to $20.00 in a research note on Thursday. Avid […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.